Cargando…
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections(†)
While 25 compounds have been formally licensed for the treatment of HIV infection (AIDS), only seven licensed products are currently available for the treatment of chronic hepatitis B virus (HBV) infection: interferon-α, pegylated interferon-α, lamivudine, adefovir (dipivoxil), entecavir, telbivudin...
Autores principales: | De Clercq, Erik, Férir, Geoffrey, Kaptein, Suzanne, Neyts, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185710/ https://www.ncbi.nlm.nih.gov/pubmed/21994680 http://dx.doi.org/10.3390/v2061279 |
Ejemplares similares
-
Antiviral strategies for hepatitis E virus
por: Debing, Yannick, et al.
Publicado: (2014) -
Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV Infection
por: Zhang, Hong, et al.
Publicado: (2020) -
Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care
por: Delang, Leen, et al.
Publicado: (2010) -
Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess the efficacy of potential antivirals
por: Tricot, Tine, et al.
Publicado: (2018) -
Molecular and Genetic Characterization of Hepatitis B Virus (HBV) among Saudi Chronically HBV-Infected Individuals
por: Di Stefano, Mariantonietta, et al.
Publicado: (2023)